We put together some data on prices for compounding. While some of it is from the almost 30 telehealth provider prices we were already tracking, most of the other data is from self reported prices from over 6,000 people we’ve polled.
Context if you haven’t been paying a ton of attention:
- Aug 8th: Eli Lilly released earnings and promised the shortage would end shortly - there wasn’t much of a fire sale on compounded.
- Aug 9th: Eli Lilly sent out cease and desists to several clinicians who were prescribing compounded tirzepatide and asked for them to confirm they would stop prescribing by Aug 16th. AFAIK only one major telehealth provider was spooked by it. All other telehealth providers and compounding pharmacies we emailed communicated that it would not disrupt business.
- Aug 27th: Eli Lilly released the vials, but there hasn’t been a huge trend of price discounts for compounded providers. Only two providers have dropped prices since then.
We’ve been tracking provider prices since April.
Highlights
- Few price drops: Only 15% of telehealth providers tracked on GLP Winner have lowered their prices since the beginning of the summer.
- Tirzepatide is our most popular search: 99% of people currently on tirzepatide wanted pricing for it. 30% of people on semaglutide were looking for tirzepatide pricing, and 65% of people not taking a GLP-1 yet were searching for tirzepatide.
- States with the highest rates of obesity had less engagement on GLP Winner: Adjusted for population, engagement on GLP Winner was the lowest from states such as Oklahoma, Kentucky, Louisiana and West Virginia.
Compounded Prices
Self reported prices are still higher than the competitively priced compounding options on GLP Winner.
Compounded GLP-1: Self Reported Prices by Dosage
($ / month)
When comparing the self reported prices to the average of the 3 cheapest providers we tracked, people were paying $75 more for compounded tirzepatide and $129 more for compounded semaglutide on average.
Compounded GLP-1: Self Reported Prices by Dosage
(mg / week)We polled over 6,000 people and 70% of them were already on a GLP-1. Most were on the 10mg dose of tirzepatide, or the equivalent for semaglutide.
Compounded GLP-1: Self Reported Dosage Breakdown
(mg / week)Fun fact
Although Bowling Green, KY has been branded as Ozempictown, USA, Kentucky ranks 45 out of 50 in terms of sessions per 100,000 residents.
Context on data
We’re tracking just under 30 telehealth provider prices and updating them when they change. Our data tends to be biased towards competitively priced telehealth options - we haven’t attempted to add every single provider that exists if they don’t seem to be a good option, we can’t verify them, or they’re very expensive/nontransparent. Our traffic and self reported prices are from visitors to GLP Winner, and we think it tends to be biased towards people on this subreddit, who are a more savvy and discerning audience as a result. We don’t think these prices are indicative of the nationwide average, and we suspect people here are paying a bit less than others who haven’t shopped around.
Additional Disclaimer
Self reported data did not explicitly identify if it was compounded or name brand, we’ve made some assumptions based off of price point. It’s possible some of the self reported data includes name brand and copays.